Inception Return
(8/25/2004)
|
6.48 %
|
|
YTD Return
|
8.87 %
|
|
NAVPS
(9/6/2024)
|
$31.99
|
|
Change
|
($0.62) / -1.91 %
|
|
|
Growth of $10,000
(As of July 31, 2024)
|
|
MER
|
2.76 %
|
|
Assets ($mil)
|
$16.12
|
|
Rank (1Yr)
|
3/66
|
|
Std Dev (3Yr)
|
17.33 %
|
|
Volatility Ranking (3Yr)
|
10/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or No Load
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund seeks to provide long-term capital growth by investing in companies located anywhere in the world that are positioned to benefit from economic growth in China. The fundamental investment objective of the Fund cannot be changed without the approval of investors who own securities in the Fund.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Ronald Chan, Manulife Investment Management Limited
Kai-Kong Chay, Manulife Investment Management Limited
Sub-Advisor
Manulife Investment Management (Hong Kong) Limited
|
|
Asset Allocation
(As of June 30, 2024)
|
Sector Allocation
(As of June 30, 2024)
|
Geographic Allocation
(As of June 30, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Taiwan Semiconductor Manufactrg Co Ltd | International Equity | Technology | Asia/Pacific Rim | 10.09% |
| Tencent Holdings Ltd | International Equity | Technology | Asia/Pacific Rim | 9.49% |
| Fubon Financial Holding Co Ltd | International Equity | Financial Services | Asia/Pacific Rim | 4.47% |
| Alibaba Group Holding Ltd | International Equity | Technology | Asia/Pacific Rim | 4.32% |
| Hon Hai Precision Industry Co Ltd | International Equity | Technology | Asia/Pacific Rim | 2.72% |
| Jentech Precision Industrial Co Ltd | International Equity | Technology | Asia/Pacific Rim | 2.69% |
| AIA Group Ltd | International Equity | Financial Services | Asia/Pacific Rim | 2.25% |
| Meituan | International Equity | Technology | Asia/Pacific Rim | 2.19% |
| Quanta Computer Inc | International Equity | Technology | Asia/Pacific Rim | 2.01% |
| Sichuan Kelun Pharmaceutical Co Ltd Cl A | International Equity | Healthcare | Asia/Pacific Rim | 1.91% |
Performance Data
(As of July 31, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-2.62
|
2.58
|
18.13
|
8.87
|
-0.37
|
-11.36
|
-1.22
|
3.47
|
|
Benchmark
|
1.02
|
-6.59
|
7.06
|
-4.97
|
-14.92
|
-10.54
|
-1.61
|
3.10
|
|
Quartile Ranking
|
3
|
1
|
1
|
1
|
1
|
3
|
3
|
3
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
-5.63
|
-25.27
|
-15.62
|
32.95
|
16.38
|
-12.27
|
40.33
|
-3.58
|
13.71
|
8.24
|
|
Benchmark
|
-12.56
|
-21.94
|
7.65
|
26.06
|
25.82
|
-27.74
|
5.92
|
-22.11
|
39.34
|
56.37
|
|
Quartile Ranking
|
1
|
4
|
3
|
2
|
3
|
3
|
1
|
4
|
3
|
4
|